Evgueni L. Saenko
About
In The Last Decade
Evgueni L. Saenko
94 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 101
- Hematology 2.8k
- Genetics 791
- Molecular Biology 761
- Radiology, Nuclear Medicine and Imaging 475
- Pulmonary and Respiratory Medicine 296
Countries citing papers authored by Evgueni L. Saenko
This map shows the geographic impact of Evgueni L. Saenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evgueni L. Saenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evgueni L. Saenko more than expected).
Fields of papers citing papers by Evgueni L. Saenko
This network shows the impact of papers produced by Evgueni L. Saenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evgueni L. Saenko. The network helps show where Evgueni L. Saenko may publish in the future.
Co-authorship network of co-authors of Evgueni L. Saenko
This figure shows the co-authorship network connecting the top 25 collaborators of Evgueni L. Saenko. A scholar is included among the top collaborators of Evgueni L. Saenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evgueni L. Saenko. Evgueni L. Saenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 14 | |
| 3 | 10 | |
| 4 | 35 | |
| 5 | 31 | |
| 6 | 17 | |
| 7 | 27 | |
| 8 | 29 | |
| 9 | 38 | |
| 10 | 7 | |
| 11 | 7 | |
| 12 | 9 | |
| 13 | The Recombinate PUP Study Group. Low factor VIII recovery in haemophilia A patients without inhibitor titre is not due to the presence of anti-factor VIII antibodies undetectable by the Bethesda assay. | 2 |
| 14 | 29 | |
| 15 | 8 | |
| 16 | 32 | |
| 17 | 179 | |
| 18 | 81 | |
| 19 | 112 | |
| 20 | 11 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.